Randall Bateman

Credentials: · · ·

History

Lecanemab in Early Alzheimer's Disease
New England Journal of Medicine · 2023 · 4,522 citations
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
New England Journal of Medicine · 2012 · First of 29 authors · Corresponding · 3,051 citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
The Lancet Neurology · 2014 · 2,536 citations

Blood Amyloid, Tau, and Neurodegeneration Biomarkers and Prediction of Clinical Onset, Cognitive Decline, and Dementia Diagnosis
National Institute on Aging · R01
Contact PI · $16.8M · Washington University
2008–2029
DIAN-TU: Tau Next Generation Prevention Trial
National Institute on Aging · R01
Contact PI · $81.4M · Washington University
2020–2027
Bridge Funding for Dominantly Inherited Alzheimer Network
National Institute on Aging · U19
Contact PI · $39.2M · Washington University
2008–2026
DIAN-TU: Next Generation Prevention Trial
National Institute on Aging · R01
Contact PI · $34.9M · Washington University
2017–2024

Study to Understand Novel Biomarkers in Researching Dementia
Principal investigator · Recruiting
Washington University School of Medicine
2024–2028
Study to Evaluate Amyloid in Blood and Imaging Related to Dementia
Principal investigator · Completed
Washington University School of Medicine
2019–2024
Human CNS Tau Kinetics in Tauopathies
Principal investigator · Completed
Washington University School of Medicine
2017–2022
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
Principal investigator · Completed
Washington University School of Medicine
2015–2023